Bone morphogenetic protein signalling is required for the anti‐mitogenic effect of the proteasome inhibitor MG‐132 on colon cancer cells
William Ka Kei Wu(Quantitative BioSciences)
Cited by 33
Related Papers
Tranexamic Acid in Patients Undergoing Noncardiac Surgery
|New England Journal of Medicine|2022|322
Hypotension-Avoidance Versus Hypertension-Avoidance Strategies in Noncardiac Surgery
|Annals of Internal Medicine|2023|153
LOX-1 acts as an N6-methyladenosine-regulated receptor for Helicobacter pylori by binding to the bacterial catalase
|Nature Communications|2024|18
Common Deregulation of Seven Biological Processes by MicroRNAs in Gastrointestinal Cancers
|Scientific Reports|2018|9